Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Hematol Oncol. 2012 Jun 26;5:33. doi: 10.1186/1756-8722-5-33.

Prognostic value of unrelated atypical serum immunofixation patterns during multiple myeloma therapy.

Abstract

Autologous stem cell transplantation (ASCT) is the gold standard therapy for suitable multiple myeloma (MM) patients after induction with high dose therapy. To date, the evidence of a reliable marker of prognosis in these cases remains scarce. Our aim was to evaluate appearance of unrelated atypical serum immunofixation patterns (ASIPs) as a marker of prognosis in MM patients submitted to ASCT. We retrospectively analysed data from 65 patients. Interestingly, we observed that presence of ASIPs was associated with longer progression-free survival and longer overall survival. Our results suggested that presence of ASIPs could be a novel marker of good prognosis in MM patients submitted to ASCT.

PMID:
22734892
[PubMed - indexed for MEDLINE]
PMCID:
PMC3426471
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk